doi: 10.2337/db18-0729 7 ZmazekJGrubelnikVMarkoviRMarhlM
Participants stigmatized an individual who had regained weight after using a GLP-1, rating them less favorably than an individual who had lost weight and maintained it (i.e., higher in negative traits, lower in positive traits, more unhealthy, less willing to affiliate) and less favorably, again, than even an individual who had not attempted weight loss (i.e., lower in positive traits)
The drug is available in pre-filled injection pens with doses ranging from 2.5 mg to 15 mg, administered once weekly
As always, treatment decisions should be made in consultation with a qualified medical professional
Sci Rep 15 , 34673 (2025)
Through this INCRETIN MIMETIC enhancement, Tradjenta restores a more physiological hormonal response to meals, helping the body manage its own metabolic markers more effectively